Literature DB >> 8370286

Nitric oxide as a target for therapy in septic shock.

J P Cobb, R E Cunnion, R L Danner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8370286     DOI： 10.1097/00003246-199309000-00003

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  4 in total

Review 1.  Immunotherapy in the management of sepsis.

Authors:  E A Fagan; M Singer
Journal:  Postgrad Med J       Date:  1995-02       Impact factor: 2.401

2.  Alpha-naphthoflavone induces vasorelaxation through the induction of extracellular calcium influx and NO formation in endothelium.

Authors:  Yu-Wen Cheng; Ching-Hao Li; Chen-Chen Lee; Jaw-Jou Kang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-15       Impact factor: 3.000

3.  An inhibitor of macrophage arginine transport and nitric oxide production (CNI-1493) prevents acute inflammation and endotoxin lethality.

Authors:  M Bianchi; P Ulrich; O Bloom; M Meistrell; G A Zimmerman; H Schmidtmayerova; M Bukrinsky; T Donnelley; R Bucala; B Sherry
Journal:  Mol Med       Date:  1995-03       Impact factor: 6.354

4.  Suppression of proinflammatory cytokines in monocytes by a tetravalent guanylhydrazone.

Authors:  M Bianchi; O Bloom; T Raabe; P S Cohen; J Chesney; B Sherry; H Schmidtmayerova; T Calandra; X Zhang; M Bukrinsky; P Ulrich; A Cerami; K J Tracey
Journal:  J Exp Med       Date:  1996-03-01       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.